BridgeBio Pharma Inc (NASDAQ:BBIO)

28.72
Delayed Data
As of Nov 30
 +0.25 / +0.88%
Today’s Change
6.64
Today|||52-Week Range
36.36
+276.90%
Year-to-Date

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for BridgeBio Pharma Inc have a median target of 50.00, with a high estimate of 60.00 and a low estimate of 28.00. The median estimate represents a +74.09% increase from the last price of 28.72.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in BridgeBio Pharma Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.72
Sales
$9.5M
Reporting Date
Feb 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 33.24%
 
 
 
 
 
 
Growthannually 2.99%
 
 
 
 
 
 

Sales

Growthquarterly 132.96%
 
 
 
 
 
 
Growthannually -73.66%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.